| Japan approves first generic biotech drug (Reuters) |
|
|
ZURICH (Reuters) - Japanese regulators approved a human growth hormone from Novartis AG, the first green light in Japan for a biosimilar or generic version of a biotech drug, the Swiss drugmaker said on Thursday. |